1-206476338-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_014002.4(IKBKE):c.516G>A(p.Ser172=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000857 in 1,613,162 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0045 ( 2 hom., cov: 31)
Exomes 𝑓: 0.00048 ( 2 hom. )
Consequence
IKBKE
NM_014002.4 synonymous
NM_014002.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -6.14
Genes affected
IKBKE (HGNC:14552): (inhibitor of nuclear factor kappa B kinase subunit epsilon) IKBKE is a noncanonical I-kappa-B (see MIM 164008) kinase (IKK) that is essential for regulating antiviral signaling pathways. IKBKE has also been identified as a breast cancer (MIM 114480) oncogene and is amplified and overexpressed in over 30% of breast carcinomas and breast cancer cell lines (Hutti et al., 2009 [PubMed 19481526]).[supplied by OMIM, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BP6
Variant 1-206476338-G-A is Benign according to our data. Variant chr1-206476338-G-A is described in ClinVar as [Benign]. Clinvar id is 721003.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-6.14 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IKBKE | NM_014002.4 | c.516G>A | p.Ser172= | synonymous_variant | 6/22 | ENST00000581977.7 | NP_054721.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IKBKE | ENST00000581977.7 | c.516G>A | p.Ser172= | synonymous_variant | 6/22 | 1 | NM_014002.4 | ENSP00000464030 | P1 | |
IKBKE | ENST00000578328.6 | c.516G>A | p.Ser172= | synonymous_variant | 6/21 | 1 | ENSP00000473833 | |||
IKBKE | ENST00000584998.5 | c.261G>A | p.Ser87= | synonymous_variant | 5/21 | 1 | ENSP00000462396 | |||
IKBKE | ENST00000605818.5 | n.861G>A | non_coding_transcript_exon_variant | 6/8 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00445 AC: 676AN: 152080Hom.: 2 Cov.: 31
GnomAD3 genomes
AF:
AC:
676
AN:
152080
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00107 AC: 267AN: 250516Hom.: 1 AF XY: 0.000768 AC XY: 104AN XY: 135362
GnomAD3 exomes
AF:
AC:
267
AN:
250516
Hom.:
AF XY:
AC XY:
104
AN XY:
135362
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000478 AC: 699AN: 1460964Hom.: 2 Cov.: 32 AF XY: 0.000416 AC XY: 302AN XY: 726718
GnomAD4 exome
AF:
AC:
699
AN:
1460964
Hom.:
Cov.:
32
AF XY:
AC XY:
302
AN XY:
726718
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00449 AC: 683AN: 152198Hom.: 2 Cov.: 31 AF XY: 0.00437 AC XY: 325AN XY: 74402
GnomAD4 genome
AF:
AC:
683
AN:
152198
Hom.:
Cov.:
31
AF XY:
AC XY:
325
AN XY:
74402
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 29, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at